Sio Gene Therapies, Inc(NASDAQ:SIOX) 
Sio Gene Therapies, Inc., a clinical-stage gene therapy company, focuses on developing various product candidates for debilitating neurodegenerative diseases. The company's clinical-stage programs include AXO-Lenti-PD program for the treatment of Parkinson's disease; AXO-AAV-GM1 program for the trea...
Website: http://www.axovant.com/
Founded: 2014
Full Time Employees: 38
CEO: Pavan Cheruvu
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-08-10
P
O 0.39
H 0.40
L 0.39
C 0.39
V 33,417
10EMA 0.39
20EMA 0.39
60EMA 0.39
120EMA 0.39
250EMA 0.39